January 16, 2013
Pfizer Inc. reached an undisclosed settlement Tuesday with a Chantix user scheduled to be the first among more than 2,000 plaintiffs to go to trial in a massive multidistrict litigation alleging the company should have known the smoking cessation drug was linked to depression and suicidal behavior.
October 18, 2012
Pfizer Inc. settled the first scheduled bellwether trial Wednesday in the multidistrict litigation in Alabama alleging the company should have known its smoking cessation drug Chantix was linked to depression and suicidal behavior, days after it failed to win a stay in the case.
October 12, 2012
Pfizer Inc. on Wednesday asked the Eleventh Circuit to overturn an order compelling its CEO and two other employees to testify in person at a bellwether trial in multidistrict litigation over alleged dangerous side effects of smoking cessation drug Chantix, saying traveling to testify would put an unlawful burden on the employees.
September 19, 2012
An Alabama federal judge on Tuesday allowed plaintiffs to add a punitive damages claim to one of the bellwether cases in multidistrict litigation alleging Pfizer Inc. should have known its smoking cessation drug Chantix was linked to depression and suicidal behavior.
August 24, 2012
An Alabama federal judge on Tuesday mostly rejected Pfizer Inc.'s attempt to toss expert testimony in a multidistrict litigation alleging the company should have known its smoking cessation drug Chantix was linked to suicidal thoughts, saying the doctors' testimonies were reliable.
July 25, 2012
An Alabama federal judge ruled Monday that black box warnings on Pfizer Inc.'s anti-smoking medicine Chantix were sufficient to warn patients about risks of suicidal thoughts, setting the stage for the drugmaker to escape a large number of cases in multidistrict litigation.